BDH Pharma, LLC, is a pharmaceutical startup with the goal of developing cannabinoid-based medications for the treatment of pain and opioid use disorders. BDH Pharma was founded by UCLA faculty/staff with the aim of commercializing their invention of a novel fixed dose combination cannabinoid-based analgesic. The mission is to improve the health of patients suffering from chronic pain and/or opioid use disorders and reduce the public health impact of opioid addiction and overdose through the development of safer and more effective alternatives to current pharmaceutical analgesics and medical marijuana.
